Results 221 to 230 of about 58,392 (301)

Targeted radionuclide therapy for gliomas: Emerging clinical trial landscape. [PDF]

Neuro Oncol
Weller M, Albert NL, Galldiks N, Bink A, Preusser M, Sulman EP, Treyer V, Wen PY, Tonn JC, Le Rhun E.   +9 more
europepmc   +1 more source

Peptide Receptor Radionuclide Therapy in Patients with Advanced, Recurrent or Progressive Meningioma: An Updated Systematic Review and Meta-Analysis. [PDF]

Cancers (Basel)
Muoio B, Iacovitti CM, Bosetti DG, Sansovini M, Cuzzocrea M, Paone G, Treglia G.   +6 more
europepmc   +1 more source

Evaluation of ¹⁷⁷Lu-Labeled Lipiodol as a Targeted Radionuclide Therapy for Hepatocellular Carcinoma in a Preclinical Xenograft Model. [PDF]

Mol Imaging Biol
Kono Y, Utsunomiya K, Shiraishi T, Kan N, Shiojima I, Maruyama K, Tanigawa N.   +6 more
europepmc   +1 more source

Targeted radionuclide therapy for patients with central nervous system metastasis: Overlooked potential? [PDF]

Neuro Oncol
Le Rhun E, Albert NL, Hüllner M, Franceschi E, Galldiks N, Karschnia P, Minniti G, Weiss T, Preusser M, Ellingson BM, Weller M.   +10 more
europepmc   +1 more source

Selection of radionuclide(s) for targeted alpha therapy based on their nuclear decay properties

Samantha M. Ree, Howard Greenwood, Jennifer D. Young, Rachel Roberts, Francis R. Livens, S.L. Heath, Jane Sosabowski   +6 more
openalex   +1 more source

Modeling Cell and Tumor-Metastasis Dosimetry with the Particle and Heavy Ion Transport Code System (PHITS) Software for Targeted Alpha-Particle Radionuclide Therapy

, 2018
Dongyoul Lee, Mengshi Li, Bryan P. Bednarz, Michael K. Schultz   +3 more
openalex   +2 more sources

Tumor microenvironment-responsive precise delivery nanocarrier potentiating synchronous radionuclide therapy and chemotherapy against cancer. [PDF]

J Nanobiotechnology
An J, Zhou Q, Chu K, Chen S, Niu C, Zhang W, Gao J, Li M, Cao J, Lv J, Zhang D, Wu Z, Li S, Wei H.   +13 more
europepmc   +1 more source

The PANEN nomogram: clinical decision support for patients with metastatic pancreatic neuroendocrine neoplasm referred for peptide receptor radionuclide therapy. [PDF]

Front Endocrinol (Lausanne)
Singh A, Sanduleanu S, Kulkarni HR, Langbein T, Lambin P, Baum RP.   +5 more
europepmc   +1 more source

131I-labeled polyethylenimine-entrapped gold nanoparticles for targeted tumor SPECT/CT imaging and radionuclide therapy

, 2019
Ning Sun, Lingzhou Zhao, Zhu J, Li Y, Na‐Young Song, Yan Xing, Wenli Qiao, He Huang, Jinhua Zhao   +8 more
openalex   +1 more source

Chelating[²²⁷Th]Th⁴⁺ for PeptideReceptor Radionuclide Therapy of Neuroendocrine Tumors

Luke Wharton (10203021), Scott W. McNeil (21312398), Harrison Meeres (20352106), Diduo Zhang (21312401), Aidan Ingham (8581506), Helen Merkens (3188421), Maryam Osooly (12192140), Cristina Rodríguez-Rodríguez (1951978), François Bénard (1558723), Hua Yang (120668)   +9 more
openalex   +1 more source